The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Practice patterns of high-risk non-muscle invasive bladder cancer (HR-NMIBC) in real-world Canadian practice.
 
Geoffrey T. Gotto
Honoraria - Astellas Pharma; AstraZeneca; Bayer; EMD Serono; Ferring; Janssen; McKesson; Merck; Pfizer; Sanofi; Tolmar
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; EMD Serono; Ferring; Janssen; McKesson; Merck; Pfizer; Sanofi; Tolmar
Research Funding - Janssen
Expert Testimony - Janssen
Travel, Accommodations, Expenses - Janssen
 
Nimira S. Alimohamed
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Bristol Myers Squibb Foundation; EMD Serono; Gilead Sciences; Janssen Oncology; Merck; Pfizer; Seagen
Research Funding - AstraZeneca Canada (Inst); EMD Serono (Inst)
 
Girish S. Kulkarni
Honoraria - Abbvie; AstraZeneca Canada; Bayer; Knight Pharmaceuticals; Photocure; Tersera
Consulting or Advisory Role - Bristol-Myers Squibb; EMD Serono; Ferring; Janssen Oncology; Merck; Pfizer; Theralase; Verity Pharmaceuticals
Research Funding - Johnson & Johnson/Janssen (Inst)
 
Peter C. Black
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Combat Medical; EMD Serono; Ferring; Janssen Oncology; Merck; Nanobot; Nanobot; NanOlogy; Nonagen Bioscience; Pfizer; Photocure; Prokarium; Protara Therapeutics; Sumitomo Pharma Oncology; TerSera; Tolmar; Verity Pharmaceuticals
Speakers' Bureau - Bayer; BioSyent; Pfizer; TerSera
Research Funding - iProgen
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.
 
Wassim Kassouf
Consulting or Advisory Role - BMS; Ferring; Janssen; Merck; Pfizer/EMD Serono; Photocure; Roche; Seagen; Sesen Bio
Research Funding - Sesen Bio (Inst)
 
Srikala S. Sridhar
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Gilead Sciences (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
Research Funding - Bayer (Inst); Janssen (Inst); Pfizer (Inst)
 
Andrea Kokorovic
Honoraria - AstraZeneca; Bayer; Janssen; Tersera
Consulting or Advisory Role - Astellas Pharma; Bayer; EMD Serono; Ferring; Janssen; Knight Therapeutics; Pfizer; Tersera; Tolmar
Travel, Accommodations, Expenses - Janssen; Tersera
 
Bernhard J. Eigl
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb/Pfizer; EMD Serono/Merck; Gilead Sciences; Janssen; Pfizer; Roche Canada; Seagen
Consulting or Advisory Role - EMD Serono; Gilead Sciences
Travel, Accommodations, Expenses - EMD Serono
 
Normand Blais
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; EMD Serono; Janssen Oncology; Merck; Novartis; Pfizer; Roche Canada; Sanofi; Takeda
Research Funding - AstraZeneca (Inst)
 
Aly-Khan A. Lalani
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Merck; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Novartis; Pfizer
Research Funding - BioCanRx (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Ipsen (Inst); Novartis (Inst); Roche (Inst)
 
Brendan J.W. Osborne
Employment - Janssen
Stock and Other Ownership Interests - Janssen
Travel, Accommodations, Expenses - Janssen
 
Christopher J.D. Wallis
Honoraria - Abbvie; Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; EMD Serono; Haymarket Medical Education; Knight Therapeutics; Merck; Tersera; Tolmar
Consulting or Advisory Role - Janssen Oncology; Nanostics; Precision Point Specialty; Sesen Bio
Research Funding - Bayer (Inst); Knight Therapeutics (Inst); Tolmar (Inst)
Travel, Accommodations, Expenses - Janssen; Knight Therapeutics; Knight Therapeutics; Tersera; Tolmar; Verity Pharmaceuticals